Sage Rhino Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.34M | Buy |
10,448
+34
| +0.3% | +$3.98K | 0.22% | 85 |
|
|
2026
Q1 | $1.25M | Buy |
10,414
+15
| +0.1% | +$1.73K | 0.23% | 84 |
|
|
2025
Q4 | $1.09M | Sell |
10,399
-155
| -1% | -$14.6K | 0.21% | 90 |
|
|
2025
Q3 | $886K | Buy |
10,554
+23
| +0.2% | +$1.89K | 0.17% | 104 |
|
|
2025
Q2 | $834K | Sell |
10,531
-50
| -0.5% | -$3.97K | 0.18% | 100 |
|
|
2025
Q1 | $950K | Buy |
10,581
+91
| +0.9% | +$8.5K | 0.22% | 85 |
|
|
2024
Q4 | $1.04M | Sell |
10,490
-57
| -0.5% | -$5.88K | 0.23% | 83 |
|
|
2024
Q3 | $1.2M | Sell |
10,547
-59
| -0.6% | -$7.01K | 0.27% | 73 |
|
|
2024
Q2 | $1.31M | Sell |
10,606
-2
| -0% | -$258 | 0.31% | 68 |
|
|
2024
Q1 | $1.4M | Buy |
10,608
+201
| +2% | +$24.8K | 0.33% | 63 |
|
|
2023
Q4 | $1.13M | Sell |
10,407
-13
| -0.1% | -$1.35K | 0.29% | 69 |
|
|
2023
Q3 | $1.07M | Buy |
10,420
+31
| +0.3% | +$3.34K | 0.3% | 70 |
|
|
2023
Q2 | $1.2M | Sell |
10,389
-36
| -0.3% | -$4.09K | 0.33% | 66 |
|
|
2023
Q1 | $1.11M | Sell |
10,425
-123
| -1% | -$13.3K | 0.32% | 64 |
|
|
2022
Q4 | $1.17M | Buy |
10,548
+24
| +0.2% | +$2.45K | 0.37% | 56 |
|
|
2022
Q3 | $906K | Sell |
10,524
-75
| -0.7% | -$6.7K | 0.36% | 50 |
|
|
2022
Q2 | $966K | Buy |
10,599
+135
| +1% | +$12K | 0.37% | 47 |
|
|
2022
Q1 | $859K | Buy |
10,464
+48
| +0.5% | +$3.78K | 0.26% | 69 |
|
|
2021
Q4 | $798K | Buy |
10,416
+63
| +0.6% | +$5.02K | 0.22% | 84 |
|
|
2021
Q3 | $778K | Buy |
10,353
+63
| +0.6% | +$4.79K | 0.24% | 72 |
|
|
2021
Q2 | $800K | Sell |
10,290
-334
| -3% | -$24.8K | 0.24% | 74 |
|
|
2021
Q1 | $781K | Sell |
10,624
-8
| -0.1% | -$590 | 0.26% | 70 |
|
|
2020
Q4 | $830K | Buy |
10,632
+70
| +0.7% | +$5.35K | 0.33% | 56 |
|
|
2020
Q3 | $836K | Buy |
10,562
+20
| +0.2% | +$1.57K | 0.4% | 49 |
|
|
2020
Q2 | $778K | Sell |
10,542
-15
| -0.1% | -$1.13K | 0.41% | 53 |
|
|
2020
Q1 | $775K | Sell |
10,557
-56
| -0.5% | -$4.4K | 0.56% | 39 |
|
|
2019
Q4 | $907K | Buy |
10,613
+51
| +0.5% | +$4.19K | 0.52% | 42 |
|
|
2019
Q3 | $848K | Buy |
10,562
+32
| +0.3% | +$2.56K | 0.53% | 42 |
|
|
2019
Q2 | $843K | Buy |
10,530
+1
| +0% | +$77 | 0.54% | 44 |
|
|
2019
Q1 | $836K | Buy |
+10,529
| New | +$787K | 0.55% | 42 |
|
Other funds holding MRK
Sage Rhino Capital's MRK Position: Q2 2026 in Review
Sage Rhino Capital increased its Merck (MRK) stake by 0.33% in Q2 2026, buying an estimated $3.98K and bringing the position to 10,448 shares worth $1.34M. The position accounts for 0.22% of the portfolio, ranked #85.
Sage Rhino Capital first reported a position in MRK in Q1 2019 and has held it in 30 quarters since. The position peaked at $1.4M in Q1 2024. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sage Rhino Capital held 10,448 shares of Merck worth $1.34M as of Q2 2026.
- Sage Rhino Capital bought 34 Merck shares in Q2 2026, an estimated $3.98K.
- Merck made up 0.22% of Sage Rhino Capital's portfolio in Q2 2026, its #85 holding.
- Sage Rhino Capital first reported a position in Merck in Q1 2019 and has held it in 30 quarters since.
- Sage Rhino Capital's Merck position peaked at $1.4M in Q1 2024.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.